Neoadjuvant immunochemotherapy vs. neoadjuvant chemotherapy or concurrent chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma. // Digestive and Liver Disease. – URL: https://www.sciencedirect.com/science/article/pii/S1590865826010303?dgcid=rss_sd_all
Neoadjuvant immunochemotherapy vs. neoadjuvant chemotherapy or concurrent chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma. Digestive and Liver Disease. https://www.sciencedirect.com/science/article/pii/S1590865826010303?dgcid=rss_sd_all
“Neoadjuvant immunochemotherapy vs. neoadjuvant chemotherapy or concurrent chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma.” Digestive and Liver Disease.
@article{article98305,
title = {Neoadjuvant immunochemotherapy vs. neoadjuvant chemotherapy or concurrent chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma},
journal = {Digestive and Liver Disease},
url = {https://www.sciencedirect.com/science/article/pii/S1590865826010303?dgcid=rss_sd_all}
}